
Saliva Stik
12 Panel Saliva Fluid Pen Drug Test Device W/ FEN
SMSPD-7126AF-FUO
AMP50, BAR50, BUP5, BZO50, COC20, MDMA50, MET50, MTD30, OPI40, OXY20, FEN20, ALCO20
as low as$2.01each
View Product →DRUG TESTING BY INDUSTRY · BULK PRICING
The legal exposure in non-DOT random testing is rarely the test itself. It's the selection logic. ASC programs ship with documented, third-party random selection criteria, audit-ready draw logs, and the panel/COC supplies to execute the test the same way every time, across every shift, every site, every quarter.

Saliva Stik
SMSPD-7126AF-FUO
AMP50, BAR50, BUP5, BZO50, COC20, MDMA50, MET50, MTD30, OPI40, OXY20, FEN20, ALCO20
as low as$2.01each
View Product →
Saliva Stik
SMSPD-4126AFK-EUO
AMP50, BAR50, BUP5, BZO50, COC20, MET50, MTD30, OPI40, OXY20, FYL20, ALCO20, K220
as low as$2.01each
View Product →
Saliva Stik
SMSPD-3126A-EUO
AMP50, BAR50, BUP5, BZO50, COC20, MET50, MTD50, OPI40, OXY20, PCP10, THC40, ALCO20
as low as$2.18each
View Product →
Saliva Stik
SMSPD-5127NTAK-EUO
AMP50, BAR50, BUP5, BZO50, COC20, MET50, MTD30, OPI40, OXY20, PCP10, FEN20, ALCO20, K220
as low as$2.14each
View Product →
Saliva Stik
SMSPD-1227NT-EUO
AMP50, BAR50, BUP5, BZO50, COC20, MDMA50, MET50, MTD30, OPI40, OXY20, PCP10, FEN20, ALCO20
as low as$2.44each
View Product →
Reveal
ASCRCUP3124NDI
THC, COC, AMP, OPI300, MAMP, PCP, BAR, BZO, MTD, MDMA, OXY, TCA
as low as$2.66each
View Product →
Reveal
REVEAL-EMP
AMP, THC, MAMP, OPI, PCP, BAR, BZO, MTD, OXY, MDMA, TCA, COC
as low as$61.13each
View Product →
ECO II
MEGAECO-03194 W/AD
6-ACM, AMP500, BAR, BUP, BZO, COC150, FEN, K2-20, KET, KRA, MAMP500, MDMA, MOR, MTD, OXY, PCP, THC20, TRA, ETG (SG/PH/OXI)
as low as$4.03each
View Product →
ECO II
MEGAEZ-03194W/AD
ACM, AMP500, BARB, BUP, BZO, COC150, FEN, K220, KET, KRA, MAMP500, MDMA, MOR, MTD, OXY, PCP, THC20, TRA, ETG (PH/SG/OX)
as low as$4.03each
View Product →
ECO II
ECOII-37124 W/AD2-ETG
AMP500, BAR, BUP, BZO, COC150, FEN, K220, MAMP500, MOR, OXY, THC, TRA100, ETG500 (CR/SG/OX)
as low as$2.99each
View Product →

Saliva Stik
SMSPD-7154-EUO
AMP50, COC20, MET50, OPI40, THC40
as low as$1.48each
View Product →
ASC
ASC-SAL-17104
THC, COC, AMP, OPI, MAMP, PCP, BAR, BZO, OXY, BUP
as low as$4.52each
View Product →
ASC
DOA-101
XYL500, FEN 10
as low as$0.55each
View Product →





ASC
WETG114
ETG 300
as low as$0.66each
View Product →



Precision Plus
PREDX-PY-114N
PSIL 300
as low as$0.51each
View Product →




Saliva Stik
SALIVASTIK-2125
AMP50, BAR50, BUP5, BZO50, COC20, MDMA50, MET50, MTD30, OPI40, OXY20, FEN20, ALC20
as low as$2.42each
View Product →
Saliva Stik
SALIVASTIK-2135
AMP50, BAR50, BUP5, BZO50, COC20, MET50, MTD30, OPI40, OXY20, PCP10, FEN20, ALC20, K220
as low as$2.71each
View Product →







No products match your filters. Try another panel count, brand or search.
True-random number generation with selection audit trails: not spreadsheets, not supervisor discretion, not the same person every quarter.
Monthly or quarterly draws on a published schedule the workforce knows. No "we forgot to test in Q3" gaps that erode the random-pool defense.
Configure the panel to match your written policy, including state-permissive marijuana exclusions for non-safety-sensitive roles where applicable.
Selection logs, COC forms, lot numbers, and result archives ready to hand to counsel when a wrongful-termination claim hits. No reconstruction required.
For non-DOT programs there's no statutory rate. Most employer programs sit between 25% and 50% annually for drugs depending on industry exposure, and rates well below that range are more likely to be challenged as performative if a case reaches deposition. Our subscription kit sizing assumes 25% as default; we can configure higher.
Operationally yes; legally we recommend against it. Excel's RAND function is not cryptographically random and selection logs maintained by the supervisor doing the selection are the first thing plaintiff's counsel attacks. Our subscription includes third-party selection: names drawn from a sealed pool, logged with a timestamp and selection-method certificate, and your supervisor never sees the pool. That structure is built to withstand EEOC and wrongful-termination challenges; spreadsheets often don't.
State law splits roughly three ways. (1) States with explicit non-discrimination for legal off-duty use (NY, NJ, CT, MN, NV, etc.): most employers exclude THC from non-safety-sensitive panels in those states. (2) Safety-sensitive roles: THC stays in regardless of state law, because impairment exposure on the job site overrides off-duty protections. (3) States without protective statutes: THC stays per written policy. ASC configures the panel to your written policy by site and role. Get the policy reviewed by employment counsel before the panel is finalized.
Many workers' comp carriers offer premium credits for documented drug-free workplace programs. The qualification standard varies but typically requires: written policy, supervisor training, pre-employment + post-accident + random testing, and EAP referral. ASC supplies the testing-supply documentation auditors verify; we can't write the policy or train your supervisors but our records hold up at carrier audit. Verify the discount eligibility with your broker; some states (Florida, Ohio, Tennessee) have statutory drug-free workplace credits.
A refusal in a written-policy random program is treated as a positive in most states for at-will employees, provided the policy clearly states refusal consequences and the employee acknowledged it at hire. Document the refusal in the COC form (we provide a refusal-notation field), note witness presence, and route to HR for policy adjudication. Don't confuse refusal with shy-bladder: true shy-bladder requires accommodation with a 3-hour rehydration window and an observed second attempt, or oral fluid as a backup specimen.
ASC supplies tamper-evident transport bags and pre-paid prepay-pack arrangements with certified reference labs (Quest, LabCorp, Clinical Reference Lab) for the LC-MS-MS confirmation step. We do not run the confirmation ourselves; that's the lab's role and we keep that separation intentional. A non-negative point-of-care result is never an employment decision; you wait for the confirmation result and the MRO interview before action.